SACGT Induces Test Maker Sponsorship Of Follow-Up Trials, Taps Myriad
This article was originally published in The Gray Sheet
Executive Summary
The HHS Secretary's Advisory Committee on Genetic Testing plans to charge its data work group with investigating the department's role in providing incentives for manufacturers to continue follow-up studies where data is lacking on clinical utility and validity for commercialized tests